HZT-501 Completed Phase 3 Trials for Peptic Ulcer Prevention

Back to HZT-501
IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT00450658Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated Ulcers